Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Manuel Alba sold 63,000 shares of the stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $63.37, for a total transaction of $3,992,310.00. Following the completion of the transaction, the director now owns 444,863 shares of the company’s stock, valued at $28,190,968.31. This represents a 12.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Astera Labs Trading Down 4.9 %
Shares of NASDAQ ALAB opened at $52.94 on Monday. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $147.39. The business has a 50-day moving average price of $78.49 and a two-hundred day moving average price of $91.05. The firm has a market capitalization of $8.58 billion and a PE ratio of -30.60.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. Research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.
Institutional Trading of Astera Labs
Analyst Upgrades and Downgrades
ALAB has been the topic of several recent analyst reports. Morgan Stanley dropped their target price on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 28th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 target price for the company in a research note on Tuesday, January 28th. Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. Raymond James began coverage on Astera Labs in a research report on Friday, March 14th. They set an “outperform” rating and a $82.00 price objective for the company. Finally, Needham & Company LLC restated a “buy” rating and issued a $140.00 target price on shares of Astera Labs in a report on Tuesday, February 11th. One analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Buy” and an average price target of $112.77.
View Our Latest Stock Report on Astera Labs
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Read More
- Five stocks we like better than Astera Labs
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- CD Calculator: Certificate of Deposit Calculator
- Disney 2025 Shareholders: Major Updates for Investors
- Short Selling – The Pros and Cons
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.